Hint mode is switched on Switch off

Immunogen, ordinary share
US45253H1014, IMGN, IMU, IMGN.P

Add a stock to WL
Immunogen, сountry — USA
No trading data
Data display in a chart | table
from
to
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
More than 2,500 records have been found, please specify your request
Latest data on

Latest quotes

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Issuer

Profile
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.
  • Issuer
  • Full borrower / issuer name
    Immunogen Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IMGN
  • Placement
    04.10.2017
  • Lock up period
    180
  • Number of papers
    13,000,000
  • Volume of raised funds
    99.45 mln USD
  • Placement share
    12.67%
  • Final placement price
    7.65 USD
  • Price change since placement date
    -
  • Capitalization at the time of placement
    784.87 mln USD

Related Stock indices

Registration is required to get access.